abstract |
The present invention relates to the use of a compound of formula (I) for the reduction of blood sugar and / or for the inhibition of the secretion, circulation, or influence of insulin antagonist peptides such as CGRP or amylin. Therefore, the compound can be used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM) or insulin resistance associated with aging.n n n Formula I |